The AHA July 26 submitted a letter expressing concerns in response to the recently introduced 340B Affording Care for Communities and Ensuring a Strong Safety-Net (340B ACCESS) Act. The bill, which purports to “establish critical oversight and transparency of the 340B program,” would dramatically diminish the program through an extremely narrow patient definition, severely limited eligibility and child site requirements, and the promise of harsh civil monetary penalties for violations.

AHA also released a new infographic that offers data-driven examples of how the 340B ACCESS Act would dismantle the 340B program and undermine its purpose — to allow eligible providers to expand access to care for more patients and communities across the country.

Related News Articles

Headline
The Health Resources and Services Administration posted on its website that it had approved eight drug company plans for participation in the 340B Rebate Model…
Headline
The Senate Committee on Health, Education, Labor and Pensions Oct. 23 held a hearing discussing the 340B Drug Pricing Program and its growth and impacts on…
Headline
The U.S. District Court for the District of Rhode Island Sept. 30 denied motions from AbbVie and Novartis seeking a preliminary injunction against the state’s…
Headline
The anticipated burdens on hospitals to comply with the Health Resources and Services Administration’s 340B Rebate Pilot Program far exceed the agency’s…
Headline
The U.S. District Court for the District of Maine today issued an order denying preliminary injunctions requested by AbbVie and Novartis in legal challenges…
Headline
The AHA commented Sept. 15 on the Centers for Medicare & Medicaid Services calendar year 2026 outpatient prospective payment system and ambulatory surgical…